-
1
-
-
0023724557
-
Compliance during treatment of epilepsy
-
Leppik IE. Compliance during treatment of epilepsy. Epilepsia 1988;29:(suppl 2):S79-84.
-
(1988)
Epilepsia
, vol.29
, Issue.2 SUPPL.
-
-
Leppik, I.E.1
-
2
-
-
0025036583
-
The evaluation and treatment of seizures
-
Scheuer ML, Pedley TA. The evaluation and treatment of seizures. N Engl J Med 1990:323;1468-74.
-
(1990)
N Engl J Med
, vol.323
, pp. 1468-1474
-
-
Scheuer, M.L.1
Pedley, T.A.2
-
3
-
-
0027530628
-
Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)
-
The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
-
(1993)
N Engl J Med
, vol.328
, pp. 29-33
-
-
-
4
-
-
0027420062
-
Felbamate: A double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures
-
Bourgeois B, Leppik IE, Sackellares JC, et al. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology 1993;43: 693-6.
-
(1993)
Neurology
, vol.43
, pp. 693-696
-
-
Bourgeois, B.1
Leppik, I.E.2
Sackellares, J.C.3
-
5
-
-
0027536726
-
Felbamate monotherapy for partial-onset seizures: An active control trial
-
Faught E, Sachdeo RC, Remler MP, et al. Felbamate monotherapy for partial-onset seizures: an active control trial. Neurology 1993;43:688-92.
-
(1993)
Neurology
, vol.43
, pp. 688-692
-
-
Faught, E.1
Sachdeo, R.C.2
Remler, M.P.3
-
6
-
-
0025934106
-
Felbamate for partial seizures: Results of a controlled clinical trial
-
Leppik IE, Dreifuss FE, Pledger GW, et al. Felbamate for partial seizures: results of a controlled clinical trial. Neurology 1991;41:1785-9.
-
(1991)
Neurology
, vol.41
, pp. 1785-1789
-
-
Leppik, I.E.1
Dreifuss, F.E.2
Pledger, G.W.3
-
7
-
-
0008617296
-
Felbamate
-
Levy RH, Mattson RH, Meldrum BS, Penry JK, Dreifuss FE, eds. New York: Raven Press
-
Leppik IE and Graves NM. Felbamate. In: Levy RH, Mattson RH, Meldrum BS, Penry JK, Dreifuss FE, eds. Antiepileptic drugs, 3rd ed. New York: Raven Press, 1989:983-90.
-
(1989)
Antiepileptic Drugs, 3rd Ed.
, pp. 983-990
-
-
Leppik, I.E.1
Graves, N.M.2
-
8
-
-
0026662642
-
Felbamate monotherapy: Controlled trial in patients with partial onset seizures
-
Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 1992;32:386-92.
-
(1992)
Ann Neurol
, vol.32
, pp. 386-392
-
-
Sachdeo, R.1
Kramer, L.D.2
Rosenberg, A.3
Sachdeo, S.4
-
9
-
-
0025834179
-
Felbamate: A clinical trial for complex partial seizures
-
Theodore WH, Raubertas RF, Porter RJ, et al. Felbamate: a clinical trial for complex partial seizures. Epilepsia 1991;32: 392-7.
-
(1991)
Epilepsia
, vol.32
, pp. 392-397
-
-
Theodore, W.H.1
Raubertas, R.F.2
Porter, R.J.3
-
10
-
-
0025911891
-
Discontinuation of phenytoin and carbamazepine in patients receiving felbamate
-
Wagner ML, Graves NM, Marienau K, Holmes GB, Remmel RP, Leppik IE. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate. Epilepsia 1991; 32:398-406.
-
(1991)
Epilepsia
, vol.32
, pp. 398-406
-
-
Wagner, M.L.1
Graves, N.M.2
Marienau, K.3
Holmes, G.B.4
Remmel, R.P.5
Leppik, I.E.6
-
11
-
-
0022364432
-
Pharmacokinetics of W-554 (ADD 03055) in epileptic patients
-
Wilensky AJ, Fuel PN, Ojemann LM, Kupferberg HK, Levy RH. Pharmacokinetics of W-554 (ADD 03055) in epileptic patients. Epilepsia 1985;26:602-6.
-
(1985)
Epilepsia
, vol.26
, pp. 602-606
-
-
Wilensky, A.J.1
Fuel, P.N.2
Ojemann, L.M.3
Kupferberg, H.K.4
Levy, R.H.5
-
12
-
-
0028054905
-
The simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin and one phenytoin metabolite in human plasma by high performance liquid chromatography
-
Romanyshyn LA, Wichmann JK, Kucharczyk N, Shumaker RC, Ward D, Sofia RD. The simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin and one phenytoin metabolite in human plasma by high performance liquid chromatography. Ther Drug Monit 1994;16:90-6.
-
(1994)
Ther Drug Monit
, vol.16
, pp. 90-96
-
-
Romanyshyn, L.A.1
Wichmann, J.K.2
Kucharczyk, N.3
Shumaker, R.C.4
Ward, D.5
Sofia, R.D.6
|